MiMedx Group (MDXG) Competitors $7.10 -0.16 (-2.20%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$7.10 0.00 (0.00%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDXG vs. TMDX, SLNO, NVST, LIVN, WRBY, INSP, EYE, PRCT, AORT, and LMATShould you be buying MiMedx Group stock or one of its competitors? The main competitors of MiMedx Group include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), National Vision (EYE), PROCEPT BioRobotics (PRCT), Artivion (AORT), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. MiMedx Group vs. Its Competitors TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems National Vision PROCEPT BioRobotics Artivion LeMaitre Vascular TransMedics Group (NASDAQ:TMDX) and MiMedx Group (NASDAQ:MDXG) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings. Which has more risk & volatility, TMDX or MDXG? TransMedics Group has a beta of 2.08, meaning that its stock price is 108% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.73, meaning that its stock price is 73% more volatile than the S&P 500. Does the media prefer TMDX or MDXG? In the previous week, TransMedics Group had 4 more articles in the media than MiMedx Group. MarketBeat recorded 6 mentions for TransMedics Group and 2 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 1.00 beat TransMedics Group's score of 0.36 indicating that MiMedx Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral MiMedx Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings & valuation, TMDX or MDXG? MiMedx Group has lower revenue, but higher earnings than TransMedics Group. MiMedx Group is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTransMedics Group$441.54M9.12$35.46M$1.9361.17MiMedx Group$348.88M3.01$42.42M$0.2133.81 Is TMDX or MDXG more profitable? TransMedics Group has a net margin of 13.49% compared to MiMedx Group's net margin of 8.84%. TransMedics Group's return on equity of 28.02% beat MiMedx Group's return on equity.Company Net Margins Return on Equity Return on Assets TransMedics Group13.49% 28.02% 8.64% MiMedx Group 8.84%23.03%17.09% Do institutionals and insiders have more ownership in TMDX or MDXG? 99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 79.2% of MiMedx Group shares are held by institutional investors. 7.0% of TransMedics Group shares are held by company insiders. Comparatively, 1.7% of MiMedx Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate TMDX or MDXG? TransMedics Group currently has a consensus target price of $125.40, suggesting a potential upside of 6.22%. MiMedx Group has a consensus target price of $12.00, suggesting a potential upside of 69.01%. Given MiMedx Group's higher probable upside, analysts plainly believe MiMedx Group is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransMedics Group 0 Sell rating(s) 6 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.50MiMedx Group 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryTransMedics Group beats MiMedx Group on 11 of the 15 factors compared between the two stocks. Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDXG vs. The Competition Export to ExcelMetricMiMedx GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.07B$3.35B$6.09B$10.54BDividend YieldN/A2.28%5.69%4.71%P/E Ratio33.8121.5785.5627.61Price / Sales3.01271.42535.65201.06Price / Cash21.9147.1237.9261.55Price / Book5.4210.1413.036.76Net Income$42.42M-$52.31M$3.30B$275.88M7 Day Performance5.81%5.14%4.35%2.81%1 Month Performance-0.28%14.68%9.50%9.24%1 Year Performance26.33%30.98%85.16%35.42% MiMedx Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDXGMiMedx Group3.386 of 5 stars$7.10-2.2%$12.00+69.0%+26.8%$1.07B$348.88M33.81870Positive NewsAnalyst ForecastTMDXTransMedics Group2.7587 of 5 stars$112.64-1.1%$125.40+11.3%-14.5%$3.88B$441.54M58.36210Analyst DowngradeSLNOSoleno Therapeutics4.398 of 5 stars$68.16+4.9%$115.09+68.9%+20.7%$3.45BN/A-16.4630Analyst ForecastNVSTEnvista3.7522 of 5 stars$20.22-0.7%$20.92+3.5%+13.1%$3.38B$2.51B63.1712,300Analyst ForecastLIVNLivaNova2.3041 of 5 stars$52.33-2.1%$59.71+14.1%+2.5%$2.92B$1.25B-13.452,900Positive NewsAnalyst ForecastWRBYWarby Parker1.8642 of 5 stars$27.69+0.3%$24.06-13.1%+50.6%$2.90B$771.32M-395.513,780Analyst ForecastINSPInspire Medical Systems4.8177 of 5 stars$75.46-2.3%$154.43+104.6%-62.0%$2.28B$802.80M43.621,246Analyst ForecastEYENational Vision2.2884 of 5 stars$29.24+2.5%$24.73-15.4%+170.0%$2.26B$1.82B-162.4413,411Positive NewsAnalyst ForecastPRCTPROCEPT BioRobotics2.9374 of 5 stars$36.49-0.5%$70.00+91.8%-53.0%$2.04B$274.95M-23.54430News CoverageAnalyst ForecastAORTArtivion2.9985 of 5 stars$42.03+2.4%$43.13+2.6%+59.6%$1.94B$388.54M-100.061,600Analyst ForecastLMATLeMaitre Vascular3.8725 of 5 stars$85.45+1.5%$97.60+14.2%-2.6%$1.91B$234.64M41.48490Analyst Forecast Related Companies and Tools Related Companies TransMedics Group Alternatives Soleno Therapeutics Alternatives Envista Alternatives LivaNova Alternatives Warby Parker Alternatives Inspire Medical Systems Alternatives National Vision Alternatives PROCEPT BioRobotics Alternatives Artivion Alternatives LeMaitre Vascular Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDXG) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share MiMedx Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
